In vitro activities of newer quinolones against Bacteroides group organisms

被引:35
作者
Snydman, DR
Jacobus, NV
McDermott, LA
Ruthazer, R
Goldstein, E
Finegold, S
Harrell, L
Hecht, DW
Jenkins, S
Pierson, C
Venezia, R
Rihs, J
Gorbach, SL
机构
[1] Tufts Univ, New England Med Ctr, Sch Med, Dept Med,Div Geog Med, Boston, MA 02111 USA
[2] Tufts Univ, New England Med Ctr, Sch Med, Dept Med,Div Infect Dis, Boston, MA 02111 USA
[3] Tufts Univ, New England Med Ctr, Sch Med, Dept Community Hlth, Boston, MA 02111 USA
[4] Tufts Univ, New England Med Ctr, Sch Med, Dept Clin Res, Boston, MA 02111 USA
[5] Univ Calif Los Angeles, Med Ctr, RM Alden Res Labs, Santa Monica, CA USA
[6] Wadsworth Vet Adm Hosp, Los Angeles, CA USA
[7] Duke Univ, Med Ctr, Durham, NC USA
[8] Carolinas Med Ctr, Charlotte, NC 28203 USA
[9] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[10] Mt Sinai Med Ctr, New York, NY 10029 USA
[11] Albany Med Ctr, Albany, NY USA
[12] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[13] Pittsburgh Vet Adm Med Ctr, Pittsburgh, PA USA
关键词
D O I
10.1128/AAC.46.10.3276-3279.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activities of BMS-284576, clinafloxacin, moxiffoxacin, sitafloxacin, trovafloxacin, imipenem, cefoxitin, and clindamycin against 589 Bacteroides fragilis group isolates were determined. The activity of BMS-284576 was comparable to that of trovafloxacin. Sitafloxacin and clinafloxacin were the most active quinolones, and moxifloxacin was the least active. B.fragilis was the most susceptible of the species, and Bacteroides vulgatus was the most resistant. Association of specific antibiotic resistance with Bacteroides species was noted for all quinolones.
引用
收藏
页码:3276 / 3279
页数:4
相关论文
共 17 条
[1]   Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species [J].
Aldridge, KE ;
Ashcraft, D ;
Cambre, K ;
Pierson, CL ;
Jenkins, SG ;
Rosenblatt, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) :1238-1243
[2]  
[Anonymous], NCCLS PUBL
[3]   BETA-LACTAMASE PRODUCTION AND SUSCEPTIBILITIES TO AMOXICILLIN, AMOXICILLIN-CLAVULANATE, TICARCILLIN, TICARCILLIN-CLAVULANATE, CEFOXITIN, IMIPENEM, AND METRONIDAZOLE OF 320 NON-BACTEROIDES-FRAGILIS-BACTEROIDES ISOLATES AND 129 FUSOBACTERIA FROM 28 UNITED-STATES CENTERS [J].
APPELBAUM, PC ;
SPANGLER, SK ;
JACOBS, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (08) :1546-1550
[4]   Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group:: Comparison with the activities of 14 other agents [J].
Betriu, C ;
Gómez, M ;
Palau, ML ;
Sánchez, A ;
Picazo, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2320-2322
[5]   COMPARATIVE ACTIVITIES OF 8 QUINOLONES AGAINST MEMBERS OF THE BACTEROIDES-FRAGILIS GROUP [J].
BOROBIO, MV ;
CONEJO, MD ;
RAMIREZ, E ;
SUAREZ, AI ;
PEREA, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1442-1445
[6]   Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms [J].
Ednie, LM ;
Jacobs, MR ;
Appelbaum, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2459-2462
[7]   Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756 [J].
Fung-Tomc, JC ;
Minassian, B ;
Kolek, B ;
Huczko, E ;
Aleksunes, L ;
Stickle, T ;
Washo, T ;
Gradelski, E ;
Valera, L ;
Bonner, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3351-3356
[8]   COMPARATIVE ACTIVITY OF CIPROFLOXACIN, OFLOXACIN, SPARFLOXACIN, TEMAFLOXACIN, CI-960, CI-990, AND WIN-57273 AGAINST ANAEROBIC-BACTERIA [J].
GOLDSTEIN, EJC ;
CITRON, DM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1158-1162
[9]  
GOLDSTEIN EJC, 1993, CLIN INFECT DIS S4, V16, P5377
[10]  
Holdeman LV., 1977, Anaerobic laboratory manual, V4